RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9578
+0.0569 (6.32%)
Jan 29, 2026, 2:49 PM EST - Market open
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $35.1 million as of January 29, 2026. Its market cap has increased by 8.34% in one year.
Market Cap
35.10M
Enterprise Value
23.21M
1-Year Change
8.34%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $35.10M, a decrease of -48.86%. That is a compound annual growth rate of -14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 33.02M | 7.24% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 34.51M |
| Reviva Pharmaceuticals Holdings | 34.24M |
| Cue Biopharma | 33.85M |
| Pluri | 33.13M |
| Hyperion DeFi | 33.00M |
| Outlook Therapeutics | 32.99M |
| AN2 Therapeutics | 32.61M |
| Skye Bioscience | 32.38M |